Trevi Therapeutics, Inc. TRVI shares are trading higher after the company announced the pricing of its $150 million offering ...
Tumor reponse, biomarker, and subgroup analyses from the VIRAGE Phase 2b clinical trial support a VCN-01 immune-mediated mode of action and ...
Background and objective Kidney transplant recipients (KTRs) face elevated cardiovascular risk, partly due to reduced ...
Background Cancer survivors often face the risk of developing heart failure (HF) as a result of their previous cancer therapy ...
VO2 max is a measure of the maximum amount of oxygen the body can handle during intense exercise. A doctor explains how it's ...
Track Global Health share price today on NSE/BSE with real-time updates. Check stock performance, fundamentals, market cap, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results